← Leaderboards
Donald M Coen
University Of Pennsylvania
$28,460,204
Attributed
$33,624,691
Total exposure
18
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$55,896,851 · 20
By mechanism
P01$29,101,732 · 12
R01$20,040,851 · 3
T32$4,639,810 · 1
R56$1,155,990 · 2
R21$958,468 · 2
Top collaborators
- James M Hogle18 shared
- David M Knipe4 shared
- Jonathan Abraham2 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Ronald N. Harty$14,036,721
Others in their field
Top investigators on “Viral”
- Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
- David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
- Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
- Judith S. Currier · University Of California Los Angeles$185,434,785
- Constance Ann Benson · University Of California, San Diego$165,517,633
Research focus
ViralVirusMutantSimplexvirusBiologicalPathogenGene ExpressionLeadIn VitroNeuronsFascinateMicrornasPropertyVirus DiseasesProteinsEquilibriumLytic PhaseVirus LatencyCombatGenesViral GenesProgramsLifeChromatin
Grant awards (110)
Project 2 - Post-transcriptional mechanisms and the HSV lytic/latent balance$549,629
P01 · FY2023 · AI · contact PI
Core C - Administrative Core$50,235
P01 · FY2023 · AI · contact PI
VIral and host mechanisms that tilt the HSV lytic/latent balance$2,129,998
P01 · FY2022 · AI · contact PI
Project 2 - Post-transcriptional mechanisms and the HSV lytic/latent balance$590,399
P01 · FY2022 · AI · contact PI
Core C - Administrative Core$50,237
P01 · FY2022 · AI · contact PI
VIral and host mechanisms that tilt the HSV lytic/latent balance$2,129,998
P01 · FY2021 · AI · contact PI
Project 2 - Post-transcriptional mechanisms and the HSV lytic/latent balance$561,108
P01 · FY2021 · AI · contact PI
Core C - Administrative Core$50,235
P01 · FY2021 · AI · contact PI
VIral and host mechanisms that tilt the HSV lytic/latent balance$2,130,974
P01 · FY2020 · AI · contact PI
Project 2 - Post-transcriptional mechanisms and the HSV lytic/latent balance$512,312
P01 · FY2020 · AI · contact PI
Structural studies of herpesvirus DNA polymerases$254,250
R21 · FY2020 · AI · contact PI
Core C - Administrative Core$95,346
P01 · FY2020 · AI · contact PI
VIral and host mechanisms that tilt the HSV lytic/latent balance$2,164,748
P01 · FY2019 · AI · contact PI
Human Cytomegalovirus Nuclear Egress: Molecular Mechanisms and Drug Targeting$789,780
R01 · FY2019 · AI · contact PI
Project 2 - Post-transcriptional mechanisms and the HSV lytic/latent balance$549,629
P01 · FY2019 · AI · contact PI
Structural studies of herpesvirus DNA polymerases$211,875
R21 · FY2019 · AI · contact PI
Core C - Administrative Core$50,235
P01 · FY2019 · AI · contact PI
Human Cytomegalovirus Nuclear Egress: Molecular Mechanisms and Drug Targeting$789,780
R01 · FY2018 · AI · contact PI
Viral And host mechanisms that tilt the HSV lytic/latent balance$1,775,175
P01 · FY2017 · AI · contact PI
Human Cytomegalovirus Nuclear Egress: Molecular Mechanisms and Drug Targeting$830,419
R01 · FY2017 · AI · contact PI
Molecular Genetics of HSV DNA Polymerase Gene$624,224
R56 · FY2017 · AI · contact PI
MicroRNAs and the HSV Lytic/Latent Balance$505,378
P01 · FY2017 · AI · contact PI
Gene Expression Core$139,471
P01 · FY2017 · AI · contact PI
Mouse Core$87,266
P01 · FY2017 · AI · contact PI
Administrative Core$63,905
P01 · FY2017 · AI · contact PI
Viral And host mechanisms that tilt the HSV lytic/latent balance$1,775,175
P01 · FY2016 · AI · contact PI
Human Cytomegalovirus Nuclear Egress: Molecular Mechanisms and Drug Targeting$789,780
R01 · FY2016 · AI · contact PI
MicroRNAs and the HSV Lytic/Latent Balance$421,223
P01 · FY2016 · AI · contact PI
Gene Expression Core$116,247
P01 · FY2016 · AI · contact PI
Mouse Core$86,811
P01 · FY2016 · AI · contact PI
Administrative Core$53,264
P01 · FY2016 · AI · contact PI
Human Cytomegalovirus Nuclear Egress: Molecular Mechanisms and Drug Targeting$40,639
R01 · FY2016 · AI · contact PI
Viral And host mechanisms that tilt the HSV lytic/latent balance$1,775,174
P01 · FY2015 · AI · contact PI
Molecular Genetics of HSV DNA Polymerase Gene$508,297
R01 · FY2015 · AI · contact PI
MicroRNAs and the HSV Lytic/Latent Balance$420,793
P01 · FY2015 · AI · contact PI
Human Cytomegalovirus Nuclear Egress: Molecular Mechanisms and Drug Targeting$394,891
R01 · FY2015 · AI · contact PI
Gene Expression Core$115,414
P01 · FY2015 · AI · contact PI
Mouse Core$86,191
P01 · FY2015 · AI · contact PI
Administrative Core$52,883
P01 · FY2015 · AI · contact PI
Viral And host mechanisms that tilt the HSV lytic/latent balance$1,732,800
P01 · FY2014 · AI · contact PI
Human Cytomegalovirus Nuclear Egress: Molecular Mechanisms and Drug Targeting$647,245
R01 · FY2014 · AI · contact PI
Molecular Genetics of HSV DNA Polymerase Gene$508,297
R01 · FY2014 · AI · contact PI
MicroRNAs and the HSV Lytic/Latent Balance$459,881
P01 · FY2014 · AI · contact PI
Antagonizing miRNAs in a strategy to cure HSV latency$227,244
R21 · FY2014 · AI · contact PI
Gene Expression Core$139,471
P01 · FY2014 · AI · contact PI
Mouse Core$87,265
P01 · FY2014 · AI · contact PI
Administrative Core$63,904
P01 · FY2014 · AI · contact PI
Viral And host mechanisms that tilt the HSV lytic/latent balance$1,487,450
P01 · FY2013 · AI · contact PI
Human Cytomegalovirus Nuclear Egress: Molecular Mechanisms and Drug Targeting$596,809
R01 · FY2013 · AI · contact PI
Molecular Genetics of HSV DNA Polymerase Gene$494,558
R01 · FY2013 · AI · contact PI
MicroRNAs and the HSV Lytic/Latent Balance$381,851
P01 · FY2013 · AI · contact PI
Pharmacological Sciences$348,004
T32 · FY2013 · GM · contact PI
Antagonizing miRNAs in a strategy to cure HSV latency$265,099
R21 · FY2013 · AI · contact PI
Gene Expression Core$114,254
P01 · FY2013 · AI · contact PI
Mouse Core$71,488
P01 · FY2013 · AI · contact PI
Administrative Core$52,351
P01 · FY2013 · AI · contact PI
Human Cytomegalovirus Nuclear Egress: Molecular Mechanisms and Drug Targeting$622,585
R01 · FY2012 · AI · contact PI
Molecular Genetics of HSV DNA Polymerase Gene$506,797
R01 · FY2012 · AI · contact PI
Pharmacological Sciences$357,236
T32 · FY2012 · GM · contact PI
Human Cytomegalovirus Nuclear Egress: Molecular Mechanisms and Drug Targeting$620,503
R01 · FY2011 · AI · contact PI
Molecular Genetics of HSV DNA Polymerase Gene$507,375
R01 · FY2011 · AI · contact PI
Pharmacological Sciences$353,504
T32 · FY2011 · GM · contact PI
Mechanism of Latency of Herpes Simplex Virus$1,283,975
P01 · FY2010 · NS · contact PI
Human Cytomegalovirus Nuclear Egress: Molecular Mechanisms and Drug Targeting$625,818
R01 · FY2010 · AI · contact PI
Molecular Genetics of HSV DNA Polymerase Gene$423,750
R01 · FY2010 · AI · contact PI
Mechanisms Regulating HSV TK Expression During Infection$370,388
R01 · FY2010 · AI · contact PI
PHARMACOLOGICAL SCIENCES$341,235
T32 · FY2010 · GM · contact PI
Mechanism of Latency of Herpes Simplex Virus$1,261,393
P01 · FY2009 · NS · contact PI
Human Cytomegalovirus Nuclear Egress: Molecular Mechanisms and Drug Targeting$531,766
R56 · FY2009 · AI · contact PI
Molecular Genetics of HSV DNA Polymerase Gene$423,541
R01 · FY2009 · AI · contact PI
Mechanisms Regulating HSV TK Expression During Infection$374,129
R01 · FY2009 · AI · contact PI
PHARMACOLOGICAL SCIENCES$348,113
T32 · FY2009 · GM · contact PI
Mechanism of Latency of Herpes Simplex Virus$169,500
P01 · FY2009 · NS · contact PI
Mechanism of Latency of Herpes Simplex Virus$1,226,829
P01 · FY2008 · NS · contact PI
A Combined Approach to Targeted Antiherpesvirus Drugs$530,947
R01 · FY2008 · AI · contact PI
Mechanisms Regulating HSV TK Expression During Infection$373,210
R01 · FY2008 · AI · contact PI
PHARMACOLOGICAL SCIENCES$346,350
T32 · FY2008 · GM · contact PI
Mechanism of Latency of Herpes Simplex Virus$1,228,971
P01 · FY2007 · NS · contact PI
A Combined Approach to Targeted Antiherpesvirus Drugs$525,469
R01 · FY2007 · AI · contact PI
Mechanisms Regulating HSV TK Expression During Infection$380,250
R01 · FY2007 · AI · contact PI
PHARMACOLOGICAL SCIENCES$346,350
T32 · FY2007 · GM · contact PI
A Combined Approach to Targeted Antiherpesvirus Drugs$525,404
R01 · FY2006 · AI · contact PI
Molecular Genetics of HSV DNA Polymerase Gene$377,906
R01 · FY2006 · AI · contact PI
PHARMACOLOGICAL SCIENCES$342,710
T32 · FY2006 · GM · contact PI
A Combined Approach to Targeted Antiherpesvirus Drugs$522,379
R01 · FY2005 · AI
Molecular Genetics of HSV DNA Polymerase Gene$387,000
R01 · FY2005 · AI
PHARMACOLOGICAL SCIENCES$287,222
T32 · FY2005 · GM
A Combined Approach to Targeted Antiherpesvirus Drugs$507,164
R01 · FY2004 · AI
Molecular Genetics of HSV DNA Polymerase Gene$387,000
R01 · FY2004 · AI
PHARMACOLOGICAL SCIENCES$342,710
T32 · FY2004 · GM
MECHANISMS REGULATING HSV TK EXPRESSION DURING INFECTION$332,810
R01 · FY2004 · AI
COMBINED APPROACH TO TARGETED ANTIHERPES VIRUS DRUGS$425,270
R01 · FY2003 · AI
Molecular Genetics of HSV DNA Polymerase Gene$387,000
R01 · FY2003 · AI
PHARMACOLOGICAL SCIENCES$335,764
T32 · FY2003 · GM
MECHANISMS REGULATING HSV TK EXPRESSION DURING INFECTION$332,810
R01 · FY2003 · AI
COMBINED APPROACH TO TARGETED ANTIHERPES VIRUS DRUGS$414,160
R01 · FY2002 · AI
Molecular Genetics of HSV DNA Polymerase Gene$387,000
R01 · FY2002 · AI
MECHANISMS REGULATING HSV TK EXPRESSION DURING INFECTION$334,140
R01 · FY2002 · AI
PHARMACOLOGICAL SCIENCES$320,108
T32 · FY2002 · GM
Regulation of HSV gene expression during latency$0
P01 · FY2002 · NS
COMBINED APPROACH TO TARGETED ANTIHERPES VIRUS DRUGS$403,374
R01 · FY2001 · AI
MECHANISMS REGULATING HSV TK EXPRESSION DURING INFECTION$336,800
R01 · FY2001 · AI
MOLECULAR GENETICS OF HSV DNA POLYMERASE GENE$318,363
R01 · FY2001 · AI
PHARMACOLOGICAL SCIENCES$304,072
T32 · FY2001 · GM
Regulation of HSV gene expression during latency$0
P01 · FY2001 · NS
COMBINED APPROACH TO TARGETED ANTIHERPES VIRUS DRUGS$341,069
R01 · FY2000 · AI
MECHANISMS REGULATING HSV TK EXPRESSION DURING INFECTION$336,800
R01 · FY2000 · AI
MOLECULAR GENETICS OF HSV DNA POLYMERASE GENE$309,145
R01 · FY2000 · AI
PHARMACOLOGICAL SCIENCES$266,432
T32 · FY2000 · GM
HSV REPLICATION, EARLY ENZYMES AND LATENCY$250,896
P01 · FY2000 · NS